Jul 2026
LINC02207 suppresses breast cancer progression by promoting cuproptosis through NFAT5 regulation.
Findings reveal a critical tumor-suppressive role of LINC02207 mediated through NFAT5-dependent regulation of cuproptosis and suggest that LINC02207 may serve as a promising therapeutic target in breast cancer.
Jicheng Chen, Xinghang Fu, Xiaotang Gao et al.
· Biochimica et Biophysica Act... · 0 citations